-
601
-
602
-
603
-
604
-
605
WASH Benefits Bangladesh trial: management structure for achieving high coverage in an efficacy trial
Published 2018-07-01Get full text
Article -
606
-
607
-
608
Left Atrial Remodeling and Stroke in Patients With Sinus Rhythm and Normal Ejection Fraction: ARIC‐NCS
Published 2022-05-01Get full text
Article -
609
-
610
-
611
-
612
Creation and Validation of a Novel Sex‐Specific Mortality Risk Score in LVAD Recipients
Published 2021-04-01Get full text
Article -
613
-
614
-
615
Variability in firearm injury among major pediatric trauma centers across the USA
Published 2023-11-01Get full text
Article -
616
Genetic risk for hospitalization of African American patients with severe mental illness reveals HLA loci
Published 2024-02-01Get full text
Article -
617
Fructosamine is Not a Reliable Test for the Detection of Hyperglycemia: Insight from the Africans in America Study
Published 2023-09-01“…Jean de Dieu Gatete,1,2,* Charlita C Worthy,1,* Ram Jagannathan,3 Christopher W DuBose,1 David B Sacks,4 Anne E Sumner1,5,6 1Section on Ethnicity and Health, Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA; 2Institute of Global Health Equity, University of Global Health Equity, Kigali, Rwanda; 3Emory Global Diabetes Research Center of Woodruff Health Sciences Center and Emory University, Rollins School of Public Health of Emory University, Atlanta, GA, USA; 4Clinical Center, National Institutes of Health, Bethesda, MD, USA; 5Hypertension in Africa Research Team, North-West University, Potchefstroom, North-West, South Africa; 6National Institute of Minority Health and Health Disparities, Bethesda, MD, USA*These authors contributed equally to this workCorrespondence: Anne E Sumner, National Institutes of Health, Bld 10-CRC, Rm 6-5940, MSC 1612, Bethesda, MD, 20892-1612, USA, Tel +1-301-402-4240, Email anne.sumner@nih.govObjective: To improve detection of abnormal glucose tolerance (Abnl-GT), attention has moved beyond the oral glucose tolerance test (OGTT), to non-fasting markers of glycemia, specifically, HbA1c, fructosamine (FA) and glycated albumin (GA). …”
Get full text
Article -
618
Measurement of body composition in postpartum South African women living with and without HIV infection
Published 2024-02-01Get full text
Article -
619
Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era
Published 2023-01-01Get full text
Article -
620